✦ LIBER ✦

Changes in the Th1/Th2 ratio during a 24-week course of an interferon alpha-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Scribed by Tomoko Fujimoto; Masahiko Tomimatsu; Daijiro Iga; Hitoshi Endo; Kuniaki Otsuka

Book ID: 108951762
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 277 KB
Volume: 23
Category: Article
ISSN: 0815-9319
DOI: 10.1111/j.1440-1746.2008.05320.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment effects and predictors of a 24

Treatment effects and predictors of a 24-week course of interferon α-2b plus ribavirin combination therapy for patients with chronic hepatitis C

✍ Masahiko Tomimatsu; Yoshio Aizawa; Yoshimichi Chuganji; Hideo Ishizuka; Yoshiyuk 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Mutations in the interferon sensitivity

Mutations in the interferon sensitivity determining region and virological response to combination therapy with pegylated-interferon alpha 2b plus ribavirin in patients with chronic hepatitis C-1b infection

✍ Mina Nakagawa; Naoya Sakamoto; Mayumi Ueyama; Kaoru Mogushi; Satoshi Nagaie; Yas 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 266 KB

Is an “à la carte” combination interfero

Is an “à la carte” combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?

✍ Thierry Poynard; John McHutchison; Zachary Goodman; Mei-Hsiu Ling; Janice Albrec 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 1 views

Randomized trials have shown the enhancement of efficacy with interferon alfa-2b and ribavirin (IFN-R) in comparison with interferon monotherapy (IFN) as first line treatment of chronic hepatitis C. Further definition of response based on disease, patient, and treatment characteristics is needed to

Effective prediction of outcome of combi

Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices

✍ Hideyuki Nomura; Yugo Miyagi; Hironori Tanimoto; Masashi Higashi; Hiromi Ishibas 📂 Article 📅 2009 🏛 Springer Japan 🌐 English ⚖ 391 KB

The effect of adherence to therapy on su

The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naïve and nonresponder chronic hepatitis C patients

✍ M. Raptopoulou; D. Tsantoulas; I. Vafiadi; I. Ketikoglou; E. Paraskevas; T. Vass 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The results of a randomized trial lookin

The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon α-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1

✍ C. Brandão; A. Barone; F. Carrilho; A. Silva; M. Patelli; C. Caramori; R. Focacc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB